PDA

View Full Version : General Cancer News

Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 [14] 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51
  1. Think Pink event offers information on breast care to lead healthier life
  2. Tiger Balm sponsors 15th annual Susan G. Komen Miami/Ft. Lauderdale Race for the Cure
  3. ACS Research Scholar Grant honors Rensselaer researcher for breast cancer study
  4. Scientists discover mechanism of anticancer drug to kill cancer cells
  5. Viral Genetics organizes trials for new therapeutic approach to treat cancer
  6. First Edition: October 15, 2010
  7. NASA software can help to interpret medical imagery
  8. Cancer 'is purely man-made' say scientists...Egyptian mummies
  9. Researchers identify genes that predict early menopause
  10. UK Intellectual Property Office allows patent for polymorph of entinostat
  11. Celgene acquires Abraxis BioScience
  12. New discovery raises hopes for women with tamoxifen resistance
  13. Free margin of 2mm from area of invasive breast cancer minimizes residual disease: St
  14. BioSante enrolls 2,500th woman in LibiGel Phase III cardiovascular and breast cancer
  15. AACR's magazine gives detail on immense challenges faced by homeless cancer patients
  16. Karmanos Cancer Institute awarded $3M NIH grant to study triple-negative breast cance
  17. Medifocus receives two patents to expand IP portfolio
  18. NCCN updates Clinical Practice Guidelines for Breast Cancer
  19. MPI of Biochemistry and GSK collaborate in development of new drugs for type 2 diabet
  20. Fatalism may prevent Latinas from using cancer screening services
  21. Health care reform will lead more people to seek cancer prevention and risk-reduction
  22. Agendia establishes contract with Humana for coverage of MammaPrint breast cancer rec
  23. Study reveals how cells crank up cancer activators
  24. More education and attention needed on inflammatory breast cancer
  25. New report focuses inflammatory breast cancer
  26. First Edition: October 20, 2010
  27. Abbott third quarter worldwide sales increase 11.8% to $8.7 billion
  28. A universal cancer treatment for a universal cancer marker
  29. FDA approves Herceptin with chemotherapy for HER2-positive metastatic cancer
  30. Menopausal estrogen replacement therapy speeds growth of ovarian cancer
  31. BIOTONE donates $5,000 to Council of Community Clinics to provide diagnostics for bre
  32. Hormone therapy increases breast cancer mortality risk, study finds
  33. Hormone therapy associated with increased risk of death from breast cancer
  34. Matrix-Bio's VeraMarker-BCR blood test predicts breast cancer recurrence 13 months be
  35. Effects of breast cancer do not end after chemotherapy
  36. Colon cancer patients seek less invasive, gentler treatments outside the US
  37. Bonati Spine Institute supports National Breast Cancer Awareness
  38. Endocrine Society's Scientific Statement clarifies menopausal hormone therapy risk fo
  39. Study demonstrates anti-prostate cancer properties of Modified Citrus Pectin
  40. New review outlines Bionovo's platform of estrogen receptor modulators
  41. Disparities in breast cancer mortality continues to be high in Chicago: Data
  42. Research could open new way to treat breast cancers
  43. Task Force: Disparities in breast cancer mortality continue to be high in Chicago
  44. Bright Starts announces 2010 Pink Power Mom winners
  45. Primary care-based patient navigation helps health care disparities
  46. Valvoline stores raises funds to fight prostate cancer
  47. Study finds metabolic syndrome may indicate breast cancer risk in post-menopausal wom
  48. Fred Hutchinson Center offers research-based tip sheets for breast cancer survivors
  49. Experts identify efficient way to increase minority access to colorectal cancer scree
  50. Research Roundup: U.S. life expectancy ratings; Medicare Advantage outlook; Should ad
  51. Researchers publish effects of doctor-designed formula against breast cancer
  52. UMC of Göttingen purchases BSD-500 Hyperthermia System
  53. CINJ researcher receives Clinical/Basic Science Research Award
  54. New research focuses on stroma tissue to treat pancreatic cancer
  55. DERMAGENICS Collagen Recovery Cream helps revitalize skin damaged by radiation, chemo
  56. New portable scanner for breast cancer diagnosis
  57. Myriad signs agreement with Abbott for BRACAnalysis
  58. New G-DOC repository for biological information
  59. Survey says americans unawareness to lung cancer
  60. ENDOMETRIN Vaginal Insert effective for luteal support in IVF procedures
  61. PSA test helps detect prostate cancer before it spreads
  62. Scientists develop new imaging technique that can detect breast cancer treatment resp
  63. Advanced procedure for microsurgical breast reconstruction offered at Baptist Health
  64. £600 million cancer drug fund for UK cancer patients
  65. Study finds green tea does not protect breast cancer
  66. Cell Therapeutics 2010 third quarter total net operating expense decreases 52% to $13
  67. Scientists suggest E-cadherin can function as oncogene in some cancers
  68. Researchers unveil evolution in pancreatic tumours
  69. IsoRay completes Cs-131 brachytherapy seeds feasibility study for breast cancer treat
  70. New oncology training program for registered nurses in Ghana
  71. ImmunoGen first quarter net loss increases to $12.9 million
  72. DiaGenic third quarter income increases from NOK -9.3 million to NOK -9.6 million
  73. Study finds genetic variants that may modify breast cancer risk among women with BRCA
  74. Research on Rictor protein may provide new molecular target for cancer treatment
  75. Merck reports $342 million net income for 2010 third quarter
  76. PUMA's Project Pink program raises funds for Women's Cancer Research Center
  77. AACR announces launch of new journal, Cancer Discovery
  78. Women with dense breasts and no lobular involution at higher risk for breast cancer
  79. Accuray to present CyberKnife Robotic Radiosurgery System at ASTRO Meeting
  80. Dance for the Cure of Prostate Cancer, national awareness and fundraising campaign la
  81. National Conference to educate breast cancer patients about personal health
  82. Gottlieb Hospital nurse raises $2,000 to fight breast cancer
  83. Two studies evaluating CyberKnife radiosurgery for breast cancer treatment to be pres
  84. Study finds breast MRI equipment in U.S. meets ACRIN and EUSOBI standards
  85. Global Genes Project launches 7,000 Bracelets for Hope campaign to create awareness a
  86. Dr Sartori’s contentious alternative therapy: inquest date set
  87. NICE to lose its power to ban life saving drugs
  88. ArcticDx develops test to determine inherited risk for AMD
  89. Celldex third quarter net loss increases to $9.1 million
  90. OncoMed receives $1.2 million to support therapeutic programs under QTDP program
  91. Celsion receives $244,000 grant under QTDP program
  92. LVI in breast tissue predicts recurrence of breast cancer in regional lymph nodes
  93. Breast cancer patients feel post-treatment breast are good in appearance
  94. New cyber-database enables access to information on lymphedema
  95. Researchers uncover regions of brain to produce unique enzyme for estrogen
  96. AVEO third quarter total collaboration revenues increase to $6.2 million
  97. Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third
  98. 'Nano-Drug' Hits Brain-Tumor Target: Unique Triggering Device Delivers Antitumor Drug
  99. FDA issues approval letter to Carestream's CR system for mammography
  100. Provectus presents PV-10 Phase 2 clinical trial data for metastatic melanoma at Sydne
  101. Researchers identify gene linked to melanoma metastasis
  102. Prolonged separation from mother increases risk of breast cancer in young mice
  103. People with SLE more likely to develop hematologic malignancies
  104. Amgen wins Scrip Best New Drug award for Prolia
  105. FDA announces reclassification for Full Field Digital Mammography Systems
  106. Parascript receives $244,479.25 federal grant under Affordable Care Act
  107. CytRx reports $4.4 million net loss for third quarter 2010
  108. Soy isoflavone intake decreases risk of invasive breast tumor
  109. Denosumab superior to Zometa in preventing SREs in breast cancer patients with bone m
  110. Obesity does not increase breast cancer risk in Mexican-American women: Research
  111. Potential biomarker for measuring progress in breast cancer chemoprevention trials
  112. Breast cancer patients prefer silicone implants for postmastectomy reconstructive sur
  113. EpiCept decreases third quarter net loss to $3.2 million
  114. Combination of optical and x-ray imaging may improve diagnostic accuracy of breast sc
  115. Genta commences tesetaxel Phase 2b clinical trial as 1st-line chemotherapy for metast
  116. Chemotherapy increases risk in breast cancer patients after surgery
  117. Smoking increases higher death rate in women with breast cancer
  118. Joint complaints attributed to breast cancer drugs not linked with inflammatory arthr
  119. NCIN reports very few lung cancer patients are eligible for surgery
  120. GTx third quarter net loss decreases to $8.6 million
  121. Provectus holds second meeting with Australian TGA to review approval of PV-10 for me
  122. Senior Scientific receives $702,899 for very early cancer detection and treatment
  123. Silence Therapeutics' Atu027 RNAi drug prevents pulmonary metastasis formation
  124. Aromatase inhibitors increase side effects in women undergoing breast cancer therapy
  125. Report analyzes global PET SPECT Market
  126. Special Surgery investigators to present future of clinical care at ACR scientific me
  127. Medicinal mushroom formula fights breast cancer
  128. COPD awareness is increasing among Americans
  129. Breast cancer patients more likely to have joint pain from taking AIs: Study
  130. Data from AVEO's tivozanib-FOLFOX6 combination Phase 1b trial presented at 22nd EORTC
  131. Epimutation in BRCA1 gene may cause early-onset of breast cancer
  132. Antigen Express awarded Therapeutic Discovery Project grants for cancer vaccine devel
  133. Alnylam presents ALN-VSP Phase I data for liver cancer at Chemotherapy Foundation Sym
  134. Cyclacel announces publication of sapacitabine to reduce tumor growth in British Jour
  135. Marker for aggressive form of idiopathic pulmonary fibrosis discovered
  136. AACR forum to focus on new advancements in cancer management among women
  137. German Genetic Diagnostics Act in need of amendment
  138. Novel mechanism regulating circadian rhythm identified
  139. Women and cancer today
  140. NCI awards $11.5 million to Fred Hutchinson Center for breast cancer research consort
  141. 33rd CTRC-AACR Symposium to feature breast cancer research
  142. SU2C to receive second CLIO Healthcare Award
  143. DS Waters extends partnership with Komen for Cure
  144. New study finds PEM reduces unnecessary breast biopsies
  145. New AccuDetect software reduces false-positive rates during mammography screening
  146. First Edition: November 15, 2010
  147. RBC boosting drugs may undermine breast cancer treatment with Herceptin
  148. FDA approves Halaven therapy for metastatic late-stage breast cancer
  149. Leona Aglukkaq announces new research on childhood obesity in Canada
  150. Merrion prepares Phase III study for Orazol in breast cancer treatment
  151. Verastem closes $16 million Series A financing
  152. AVEO commences enrollment in Phase 1b combination trial of tivozanib with oral capeci
  153. Scientists find inhibiting EGFR may help treat triple negative breast cancer
  154. Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Sympo
  155. New OncoMap technique can detect point mutation in ovarian cancer
  156. Targeted therapies could treat broad range of cancers: Research
  157. Risk of radiation-induced breast cancer from mammographic screening slight in compari
  158. Cancer patients can still access NICE rejected drugs
  159. U-Systems initiates EASY study for screening breast cancer
  160. Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer
  161. Scientists develop new method for detecting functional sites on proteins
  162. New technique to identify cancer biomarkers
  163. MK-4827 drug candidate shows promising anti-tumour activity in first human trial
  164. Exelixis reports interim data of XL184 for metastatic castration-resistant prostate c
  165. DiaGenic receives 92,738,974 shares in subsequent offering
  166. Multidisciplinary clinic approach can improve survival in patients with aggressive pr
  167. COPD both a burden and a loss
  168. Clinical data of CU-201, CUDC-101 presented at EORTC-NCI-AACR Symposium
  169. Volpara breast imaging software receives FDA clearance
  170. AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointe
  171. Mouse study finds blocking GnT-V enzyme delays growth of breast cancer
  172. Cough suppressant syrup can probe patients' metabolism on tamoxifen for breast cancer
  173. ZIOPHARM announces data on darinaparsin efficacy for solid tumors at EORTC-NCI-AACR S
  174. AVEO's RON antibody shows anti-tumor activity in human cancer xenografts
  175. Xgeva receives FDA approval for prevention of SREs in patients with bone metastases
  176. New I-SPY 2 study to evaluate effectiveness of medical treatment for breast cancer
  177. Phase 3 study of VEGF Trap-Eye regimen meets primary endpoint in patients with wet AM
  178. IsoRay to sell $2.25 million in common stock
  179. S*BIO's SB1317 enters Phase 1 clinical trial in patients with advanced/refractory hem
  180. DiaGenic ASA announces subsequent offering of 60,000,000 shares
  181. Hologic announces receipt of FDA approvable letter for Selenia Dimensions 3-D digital
  182. IDSI submits Premarket Notification for CTLM breast imaging device to FDA
  183. Disrupting estrogen pathway can halt expansion of breast cancer stem cells: Research
  184. Provectus reports progress in PV-10 program for metastatic melanoma
  185. Blocking miR-375 microRNA in ERalha-positive breast cancer cells slows down cancer ce
  186. A new treatment landscape for triple-negative breast cancer
  187. Does anybody know where I can find a good iseries web site with technical data?
  188. Cancers detected late leading to unnecessary deaths: Report
  189. LCA calls for public discussion on guidance for lung cancer screening
  190. Researchers explain molecular mechanism that induces HER2+ tumours to ignore cell sig
  191. Personalized oncology requires new paradigm for drug development, experts say
  192. IMPAX for breast imaging eliminates limitations of modality-specific review stations
  193. GE Healthcare to highlight technologies to support healthymagination strategy at RSNA
  194. ACS recommends annual MRI screening in women with family history of breast cancer
  195. Texas Breast Specialists expands breast cancer treatment services
  196. Baylor Health Care System receives $20 million to benefit transplantation initiatives
  197. Positive results from Oncolytics' combination REOLYSIN-docetaxel Phase I trial in adv
  198. New findings suggest targeting DNA in later-stage could be effective to treat breast
  199. U-Systems upgrades ABUS system to improve diagnostic efficiency, quality
  200. Genetic screening for Lynch syndrome as cost-effective as other cancer screening proc
  201. University Hospitals receives $42 million for cancer care
  202. Data on UCB’s anti-epileptic drugs to be presented at AES annual meeting
  203. Study shows link between reduced hormone therapy and decline in breast cancer
  204. Annual mammography screening reduces risk of mastectomy
  205. Men with long index fingers at lower risk of prostate cancer
  206. Precision Therapeutics to present abstracts on breast cancer therapy at San Antonio S
  207. Debiopharm recognised with European Biopharmaceuticals company of the year award
  208. British Journal: Obesity, alcohol consumption may increase cancer risk
  209. Regis Corporation raises $1 million for breast cancer research
  210. Dec. 1 news from RSNA 2010
  211. Breast cancer breakthrough
  212. Bare breasts campaign for breast cancer
  213. Study identifies new genes for early menarche
  214. CTRC-AACR Symposium to discuss new findings from breast cancer clinical trial
  215. Study finds anastrozole long-term benefits to stop breast cancer
  216. New radiation-free device to detect breast cancer
  217. Lexus of Tacoma donates $3,000 to Carol Milgard Breast Center
  218. AVEO to present data on tivozanib Phase 1b trial for breast cancer at SABCS Symposium
  219. News segment highlights value of hyperthermia for treatment of breast cancer
  220. Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting
  221. Geron commences enrollment in imetelstat Phase 2 clinical trial for metastatic breast
  222. Quebec Foundation invests $5 million for breast cancer research
  223. Doctors still prescribe higher-dose menopausal hormone therapy pills
  224. Experts reach consensus on beneficial effects of Soy
  225. Johns Hopkins patient-safety tools help reduce lethal bloodstream infections
  226. Review shows need for standardized approach to outcome assessment in breast reconstru
  227. Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study
  228. New standard treatment for early stage breast cancer
  229. URMC's Cone Beam CT scanner studies presented at RSNA 2010
  230. Clinical studies participated by three investigators to be presented at ASH Annual Me
  231. KIRN 670AM RADIOIRAN to create new awareness about prostate cancer
  232. Seven studies on Oncotype DX breast cancer test to be presented at 33rd CTRC-AACR SAB
  233. New research focusing on VTE presented at ASH Annual Meeting
  234. Suche erotische Kontakte
  235. Preclinical data of ZIO-101 in various lymphoma models presented at ASH 2010
  236. Investigator recommends screening mammogram during first week of menstrual cycle
  237. NanoString secures exclusive worldwide license to develop products for breast cancer
  238. Cylene Pharmaceuticals to present data on CK2 inhibitor at ASH Annual Meeting
  239. A new analysis for a substantial role of genes in susceptibility to the major human
  240. Protein alpha-2-beta-1 integrin suppresses metastasis
  241. Breast cancer patients taking tamoxifen anxious to have CYP2D6 genetic test
  242. Roche completes enrollment in Herceptin SC Phase 3 trial for HER2-positive breast can
  243. North Tees and Hartlepool NHS Foundation Trust pioneer novel technique for breast rec
  244. MassMutual broadens life insurance underwriting guidelines for prostate cancer surviv
  245. AltheaDx partners with Compendia Bioscience to launch Breast Cancer Segregation Panel
  246. Bionovo demonstrates ERb cancer prevention mechanism
  247. Annual survey ranks states on health, health care
  248. Weightlifting causes no harm for women with breast cancer-related lymphedema
  249. New report indicates that struggling economy may have reduced use of preventive care
  250. Clarient introduces Mammostrat test to quantify likelihood of breast cancer recurrenc